Literature DB >> 33779337

Successful management of pediatric pythium insidiosum keratitis with cyanoacrylate glue, linezolid, and azithromycin: Rare case report.

Bharat Gurnani1, Shivananda Narayana1, Josephine Christy1, Purushothama Rajkumar1, Kirandeep Kaur2, Joseph Gubert3.   

Abstract

PURPOSE: Pythium insidiosum causes a rare sight-threatening keratitis and is a devastating ocular pathology with a high morbidity. It is frequently mistaken as fungal keratitis. Here we highlight a rare case of pediatric Pythium insidiosum keratitis which was successfully managed using an antibiotic combination of linezolid and azithromycin with cyanoacrylate glue. CASE DESCRIPTION: A 9-year-old young male child presented to our clinic with defective vision, pain, redness in the right eye for 5 days post stick injury. In the right eye, Snellen's best-corrected visual acuity (BCVA) was 6/12 which deteriorated to hand movements within 5 days of treatment. Ocular examination revealed 6 × 5 mm dry-looking mid stromal corneal infiltrate with feathery margin involving the visual axis. The clinical picture was suggestive of fungal keratitis. Corneal scraping and smear examination with 10% KOH and Gram stain revealed long slender hyaline hyphae with sparse septations. Before the culture result, the patient was started on 5% Natamycin and 1% Itraconazole hourly, but still, the infiltrate progressed. Further, P. Insidiosum keratitis was considered as the differential, which was confirmed on blood agar culture. After receiving culture results, the patient was managed with 0.2% Linezolid and 1% Azithromycin hourly. Due to the rapid progression of infiltrate, corneal melt, and younger age, cyanoacrylate glue, and bandage contact lens were used. On the last follow-up, the BCVA recovered to 6/12. CONCLUSION AND IMPORTANCE: Prompt diagnosis, clinical awareness, and a specific treatment regime is needed for managing this devastating corneal entity. Cyanoacrylate glue due to its antibacterial properties can be a potential rescuer and can be considered for managing these cases.

Entities:  

Keywords:  Pythium insidiosum keratitis; azithromycin; cyanoacrylate glue; linezolid; pediatric

Mesh:

Substances:

Year:  2021        PMID: 33779337     DOI: 10.1177/11206721211006564

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  5 in total

1.  Role of Immunotherapy in Pythium insidiosum Keratitis.

Authors:  Onsiri Thanathanee; Chavakij Bhoomibunchoo; Orapin Anutarapongpan; Olan Suwan-Apichon; Korawin Charoensuk; Ariya Chindamporn
Journal:  Am J Trop Med Hyg       Date:  2022-06-06       Impact factor: 3.707

Review 2.  Pythium insidiosum Keratitis: Past, Present, and Future.

Authors:  Bharat Gurnani; Kirandeep Kaur; Shweta Agarwal; Vaitheeswaran G Lalgudi; Nakul S Shekhawat; Anitha Venugopal; Koushik Tripathy; Bhaskar Srinivasan; Geetha Iyer; Joseph Gubert
Journal:  Ophthalmol Ther       Date:  2022-07-05

Review 3.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

4.  Global Distribution and Clinical Features of Pythiosis in Humans and Animals.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  J Fungi (Basel)       Date:  2022-02-11

Review 5.  Pythium insidiosum keratitis - A review.

Authors:  Bharat Gurnani; Kirandeep Kaur; Anitha Venugopal; Bhaskar Srinivasan; Bhupesh Bagga; Geetha Iyer; Josephine Christy; Lalitha Prajna; Murugesan Vanathi; Prashant Garg; Shivanand Narayana; Shweta Agarwal; Srikant Sahu
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.